Copper Drug Revolutionizes Alzheimer’s Treatment by Restoring Memory
Discover how a copper transport drug is changing Alzheimer’s treatment protocols, emphasizing the importance of minerals in cognitive health.
neurodegenerative diseases
Only 2 New Alzheimer’s Drugs Approved in 20 Years: What’s Going Wrong?
Despite $2.6 billion in funding, only 2 new Alzheimer’s drugs were approved in two decades, highlighting systemic failures in biotech.